nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentostatin—Nucleic Acid Synthesis Inhibitors—Gemcitabine—urinary bladder cancer	0.362	0.515	CiPCiCtD
Pentostatin—Nucleic Acid Synthesis Inhibitors—Fluorouracil—urinary bladder cancer	0.341	0.485	CiPCiCtD
Pentostatin—Azacitidine—Gemcitabine—urinary bladder cancer	0.106	0.512	CrCrCtD
Pentostatin—Decitabine—Gemcitabine—urinary bladder cancer	0.101	0.488	CrCrCtD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—KRT5—urinary bladder cancer	0.002	0.0869	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—PTCRA—urinary bladder cancer	0.00138	0.0597	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—TP63—urinary bladder cancer	0.00121	0.0526	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—TP63—urinary bladder cancer	0.00109	0.0471	CbGpPWpGaD
Pentostatin—ADA—prostate gland—urinary bladder cancer	0.000967	0.329	CbGeAlD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—IGFBP3—urinary bladder cancer	0.000954	0.0413	CbGpPWpGaD
Pentostatin—Floxuridine—TYMP—urinary bladder cancer	0.000927	0.334	CrCbGaD
Pentostatin—ADA—Nucleotide metabolism—TYMP—urinary bladder cancer	0.000885	0.0384	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—IGFBP3—urinary bladder cancer	0.000854	0.037	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—TP63—urinary bladder cancer	0.000802	0.0347	CbGpPWpGaD
Pentostatin—ADA—Purine metabolism—GPX1—urinary bladder cancer	0.000754	0.0327	CbGpPWpGaD
Pentostatin—Trifluridine—TYMP—urinary bladder cancer	0.000736	0.265	CrCbGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—JAG1—urinary bladder cancer	0.000729	0.0316	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—BIRC3—urinary bladder cancer	0.000696	0.0302	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—NQO1—urinary bladder cancer	0.000692	0.03	CbGpPWpGaD
Pentostatin—ADA—Nucleotide metabolism—RRM2—urinary bladder cancer	0.000691	0.03	CbGpPWpGaD
Pentostatin—ADA—renal system—urinary bladder cancer	0.000659	0.224	CbGeAlD
Pentostatin—ADA—C-MYB transcription factor network—MPO—urinary bladder cancer	0.000596	0.0258	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.000583	0.0253	CbGpPWpGaD
Pentostatin—ADA—female reproductive system—urinary bladder cancer	0.000528	0.18	CbGeAlD
Pentostatin—ADA—vagina—urinary bladder cancer	0.000477	0.162	CbGeAlD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—FAS—urinary bladder cancer	0.000476	0.0206	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—ATM—urinary bladder cancer	0.00047	0.0204	CbGpPWpGaD
Pentostatin—Floxuridine—TYMS—urinary bladder cancer	0.000436	0.157	CrCbGaD
Pentostatin—ADA—Nucleotide metabolism—TYMS—urinary bladder cancer	0.0004	0.0173	CbGpPWpGaD
Pentostatin—ADA—Nucleotide metabolism—GPX1—urinary bladder cancer	0.000379	0.0164	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—GSTM1—urinary bladder cancer	0.000373	0.0162	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—NCOR1—urinary bladder cancer	0.000373	0.0162	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—urinary bladder cancer	0.000358	0.0155	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—FAS—urinary bladder cancer	0.000351	0.0152	CbGpPWpGaD
Pentostatin—Trifluridine—TYMS—urinary bladder cancer	0.000346	0.125	CrCbGaD
Pentostatin—Cladribine—RRM2—urinary bladder cancer	0.000329	0.119	CrCbGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN2A—urinary bladder cancer	0.00032	0.0139	CbGpPWpGaD
Pentostatin—ADA—lymph node—urinary bladder cancer	0.000309	0.105	CbGeAlD
Pentostatin—ADA—p73 transcription factor network—RB1—urinary bladder cancer	0.000269	0.0116	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—CDKN1A—urinary bladder cancer	0.000262	0.0113	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000257	0.0111	CbGpPWpGaD
Pentostatin—ADA—Validated transcriptional targets of TAp63 isoforms—EP300—urinary bladder cancer	0.000249	0.0108	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	0.000225	0.00974	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—PTGS2—urinary bladder cancer	0.00021	0.00911	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—CDKN1A—urinary bladder cancer	0.000193	0.00836	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CCND1—urinary bladder cancer	0.00019	0.00823	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000188	0.00813	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000185	0.00804	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	0.000184	0.00796	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—EP300—urinary bladder cancer	0.000184	0.00796	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—EP300—urinary bladder cancer	0.000175	0.00757	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—FAS—urinary bladder cancer	0.000166	0.00721	CbGpPWpGaD
Pentostatin—ADA—p73 transcription factor network—MYC—urinary bladder cancer	0.00016	0.00693	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—MYC—urinary bladder cancer	0.000152	0.0066	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000146	0.00634	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—KRAS—urinary bladder cancer	0.000141	0.0061	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GSTZ1—urinary bladder cancer	0.00014	0.00607	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000133	0.00576	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GSTO2—urinary bladder cancer	0.000133	0.00575	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NAT1—urinary bladder cancer	0.000133	0.00575	CbGpPWpGaD
Pentostatin—ADA—Metabolism—UGT2B7—urinary bladder cancer	0.000121	0.00526	CbGpPWpGaD
Pentostatin—ADA—C-MYB transcription factor network—HRAS—urinary bladder cancer	0.00012	0.00518	CbGpPWpGaD
Pentostatin—ADA—Metabolism—CYP4B1—urinary bladder cancer	0.000109	0.00474	CbGpPWpGaD
Pentostatin—ADA—Metabolism—SLC19A1—urinary bladder cancer	0.000103	0.00447	CbGpPWpGaD
Pentostatin—ADA—Metabolism—PRSS3—urinary bladder cancer	0.000101	0.00436	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—PTEN—urinary bladder cancer	9.12e-05	0.00395	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—EP300—urinary bladder cancer	8.7e-05	0.00377	CbGpPWpGaD
Pentostatin—ADA—Metabolism—TYMP—urinary bladder cancer	8.04e-05	0.00349	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NAT2—urinary bladder cancer	7.27e-05	0.00315	CbGpPWpGaD
Pentostatin—ADA—Metabolism—RRM2—urinary bladder cancer	6.28e-05	0.00272	CbGpPWpGaD
Pentostatin—ADA—Circadian rythm related genes—TP53—urinary bladder cancer	6.22e-05	0.0027	CbGpPWpGaD
Pentostatin—ADA—Metabolism—HPGDS—urinary bladder cancer	5.82e-05	0.00252	CbGpPWpGaD
Pentostatin—ADA—Metabolism—ENO2—urinary bladder cancer	5.82e-05	0.00252	CbGpPWpGaD
Pentostatin—ADA—Metabolism—GSTT1—urinary bladder cancer	5.64e-05	0.00244	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NQO1—urinary bladder cancer	4.69e-05	0.00203	CbGpPWpGaD
Pentostatin—Paraesthesia—Etoposide—urinary bladder cancer	4.65e-05	0.000754	CcSEcCtD
Pentostatin—Dyspnoea—Etoposide—urinary bladder cancer	4.62e-05	0.000749	CcSEcCtD
Pentostatin—Somnolence—Etoposide—urinary bladder cancer	4.61e-05	0.000746	CcSEcCtD
Pentostatin—Angina pectoris—Doxorubicin—urinary bladder cancer	4.6e-05	0.000746	CcSEcCtD
Pentostatin—Vomiting—Thiotepa—urinary bladder cancer	4.59e-05	0.000743	CcSEcCtD
Pentostatin—Pneumonia—Epirubicin—urinary bladder cancer	4.58e-05	0.000742	CcSEcCtD
Pentostatin—Rash—Thiotepa—urinary bladder cancer	4.55e-05	0.000737	CcSEcCtD
Pentostatin—Bronchitis—Doxorubicin—urinary bladder cancer	4.54e-05	0.000736	CcSEcCtD
Pentostatin—Dermatitis—Thiotepa—urinary bladder cancer	4.54e-05	0.000736	CcSEcCtD
Pentostatin—Agranulocytosis—Methotrexate—urinary bladder cancer	4.54e-05	0.000736	CcSEcCtD
Pentostatin—Headache—Thiotepa—urinary bladder cancer	4.52e-05	0.000732	CcSEcCtD
Pentostatin—Decreased appetite—Etoposide—urinary bladder cancer	4.5e-05	0.00073	CcSEcCtD
Pentostatin—Renal failure—Epirubicin—urinary bladder cancer	4.48e-05	0.000725	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	4.47e-05	0.000725	CcSEcCtD
Pentostatin—Body temperature increased—Cisplatin—urinary bladder cancer	4.47e-05	0.000724	CcSEcCtD
Pentostatin—Fatigue—Etoposide—urinary bladder cancer	4.47e-05	0.000724	CcSEcCtD
Pentostatin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	4.46e-05	0.000723	CcSEcCtD
Pentostatin—Stomatitis—Epirubicin—urinary bladder cancer	4.44e-05	0.000719	CcSEcCtD
Pentostatin—Constipation—Etoposide—urinary bladder cancer	4.43e-05	0.000718	CcSEcCtD
Pentostatin—Pain—Etoposide—urinary bladder cancer	4.43e-05	0.000718	CcSEcCtD
Pentostatin—Conjunctivitis—Epirubicin—urinary bladder cancer	4.43e-05	0.000717	CcSEcCtD
Pentostatin—Urinary tract infection—Epirubicin—urinary bladder cancer	4.43e-05	0.000717	CcSEcCtD
Pentostatin—Hypersensitivity—Fluorouracil—urinary bladder cancer	4.4e-05	0.000712	CcSEcCtD
Pentostatin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	4.39e-05	0.000712	CcSEcCtD
Pentostatin—Haemoglobin—Methotrexate—urinary bladder cancer	4.39e-05	0.000711	CcSEcCtD
Pentostatin—Haemorrhage—Methotrexate—urinary bladder cancer	4.37e-05	0.000708	CcSEcCtD
Pentostatin—Sweating—Epirubicin—urinary bladder cancer	4.37e-05	0.000707	CcSEcCtD
Pentostatin—Asthenia—Gemcitabine—urinary bladder cancer	4.35e-05	0.000705	CcSEcCtD
Pentostatin—Pharyngitis—Methotrexate—urinary bladder cancer	4.34e-05	0.000703	CcSEcCtD
Pentostatin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	4.31e-05	0.000699	CcSEcCtD
Pentostatin—Pruritus—Gemcitabine—urinary bladder cancer	4.29e-05	0.000696	CcSEcCtD
Pentostatin—Nausea—Thiotepa—urinary bladder cancer	4.28e-05	0.000694	CcSEcCtD
Pentostatin—Sinusitis—Epirubicin—urinary bladder cancer	4.27e-05	0.000692	CcSEcCtD
Pentostatin—Feeling abnormal—Etoposide—urinary bladder cancer	4.27e-05	0.000692	CcSEcCtD
Pentostatin—Agranulocytosis—Epirubicin—urinary bladder cancer	4.25e-05	0.000689	CcSEcCtD
Pentostatin—Pneumonia—Doxorubicin—urinary bladder cancer	4.24e-05	0.000687	CcSEcCtD
Pentostatin—Gastrointestinal pain—Etoposide—urinary bladder cancer	4.24e-05	0.000687	CcSEcCtD
Pentostatin—Pruritus—Fluorouracil—urinary bladder cancer	4.22e-05	0.000684	CcSEcCtD
Pentostatin—Visual impairment—Methotrexate—urinary bladder cancer	4.21e-05	0.000682	CcSEcCtD
Pentostatin—Hypersensitivity—Cisplatin—urinary bladder cancer	4.17e-05	0.000675	CcSEcCtD
Pentostatin—Bradycardia—Epirubicin—urinary bladder cancer	4.16e-05	0.000674	CcSEcCtD
Pentostatin—Diarrhoea—Gemcitabine—urinary bladder cancer	4.15e-05	0.000673	CcSEcCtD
Pentostatin—Renal failure—Doxorubicin—urinary bladder cancer	4.14e-05	0.000671	CcSEcCtD
Pentostatin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	4.13e-05	0.000669	CcSEcCtD
Pentostatin—Urticaria—Etoposide—urinary bladder cancer	4.12e-05	0.000667	CcSEcCtD
Pentostatin—Haemoglobin—Epirubicin—urinary bladder cancer	4.11e-05	0.000666	CcSEcCtD
Pentostatin—Stomatitis—Doxorubicin—urinary bladder cancer	4.11e-05	0.000666	CcSEcCtD
Pentostatin—Rhinitis—Epirubicin—urinary bladder cancer	4.1e-05	0.000664	CcSEcCtD
Pentostatin—Body temperature increased—Etoposide—urinary bladder cancer	4.1e-05	0.000664	CcSEcCtD
Pentostatin—Abdominal pain—Etoposide—urinary bladder cancer	4.1e-05	0.000664	CcSEcCtD
Pentostatin—Urinary tract infection—Doxorubicin—urinary bladder cancer	4.1e-05	0.000664	CcSEcCtD
Pentostatin—Conjunctivitis—Doxorubicin—urinary bladder cancer	4.1e-05	0.000664	CcSEcCtD
Pentostatin—Haemorrhage—Epirubicin—urinary bladder cancer	4.09e-05	0.000662	CcSEcCtD
Pentostatin—Diarrhoea—Fluorouracil—urinary bladder cancer	4.08e-05	0.000661	CcSEcCtD
Pentostatin—Tinnitus—Methotrexate—urinary bladder cancer	4.07e-05	0.00066	CcSEcCtD
Pentostatin—Asthenia—Cisplatin—urinary bladder cancer	4.06e-05	0.000658	CcSEcCtD
Pentostatin—Pharyngitis—Epirubicin—urinary bladder cancer	4.06e-05	0.000657	CcSEcCtD
Pentostatin—Sweating—Doxorubicin—urinary bladder cancer	4.04e-05	0.000655	CcSEcCtD
Pentostatin—Oedema peripheral—Epirubicin—urinary bladder cancer	4.03e-05	0.000653	CcSEcCtD
Pentostatin—Sinusitis—Doxorubicin—urinary bladder cancer	3.95e-05	0.000641	CcSEcCtD
Pentostatin—Dizziness—Fluorouracil—urinary bladder cancer	3.94e-05	0.000639	CcSEcCtD
Pentostatin—Visual impairment—Epirubicin—urinary bladder cancer	3.94e-05	0.000638	CcSEcCtD
Pentostatin—Agranulocytosis—Doxorubicin—urinary bladder cancer	3.93e-05	0.000637	CcSEcCtD
Pentostatin—Chills—Methotrexate—urinary bladder cancer	3.92e-05	0.000635	CcSEcCtD
Pentostatin—ADA—Metabolism—GSTP1—urinary bladder cancer	3.91e-05	0.00169	CbGpPWpGaD
Pentostatin—Diarrhoea—Cisplatin—urinary bladder cancer	3.87e-05	0.000627	CcSEcCtD
Pentostatin—Alopecia—Methotrexate—urinary bladder cancer	3.86e-05	0.000626	CcSEcCtD
Pentostatin—Vomiting—Gemcitabine—urinary bladder cancer	3.86e-05	0.000625	CcSEcCtD
Pentostatin—Bradycardia—Doxorubicin—urinary bladder cancer	3.85e-05	0.000624	CcSEcCtD
Pentostatin—Rash—Gemcitabine—urinary bladder cancer	3.83e-05	0.00062	CcSEcCtD
Pentostatin—Dermatitis—Gemcitabine—urinary bladder cancer	3.82e-05	0.000619	CcSEcCtD
Pentostatin—Hypersensitivity—Etoposide—urinary bladder cancer	3.82e-05	0.000619	CcSEcCtD
Pentostatin—Tinnitus—Epirubicin—urinary bladder cancer	3.81e-05	0.000618	CcSEcCtD
Pentostatin—Haemoglobin—Doxorubicin—urinary bladder cancer	3.8e-05	0.000616	CcSEcCtD
Pentostatin—Headache—Gemcitabine—urinary bladder cancer	3.8e-05	0.000616	CcSEcCtD
Pentostatin—Vomiting—Fluorouracil—urinary bladder cancer	3.79e-05	0.000615	CcSEcCtD
Pentostatin—Rhinitis—Doxorubicin—urinary bladder cancer	3.79e-05	0.000615	CcSEcCtD
Pentostatin—Haemorrhage—Doxorubicin—urinary bladder cancer	3.78e-05	0.000613	CcSEcCtD
Pentostatin—Rash—Fluorouracil—urinary bladder cancer	3.76e-05	0.00061	CcSEcCtD
Pentostatin—Dermatitis—Fluorouracil—urinary bladder cancer	3.76e-05	0.000609	CcSEcCtD
Pentostatin—Pharyngitis—Doxorubicin—urinary bladder cancer	3.75e-05	0.000608	CcSEcCtD
Pentostatin—Headache—Fluorouracil—urinary bladder cancer	3.74e-05	0.000606	CcSEcCtD
Pentostatin—Oedema peripheral—Doxorubicin—urinary bladder cancer	3.73e-05	0.000604	CcSEcCtD
Pentostatin—Asthenia—Etoposide—urinary bladder cancer	3.72e-05	0.000602	CcSEcCtD
Pentostatin—Chills—Epirubicin—urinary bladder cancer	3.67e-05	0.000594	CcSEcCtD
Pentostatin—Pruritus—Etoposide—urinary bladder cancer	3.67e-05	0.000594	CcSEcCtD
Pentostatin—Arrhythmia—Epirubicin—urinary bladder cancer	3.65e-05	0.000592	CcSEcCtD
Pentostatin—Visual impairment—Doxorubicin—urinary bladder cancer	3.64e-05	0.000591	CcSEcCtD
Pentostatin—ADA—Metabolism—TYMS—urinary bladder cancer	3.63e-05	0.00158	CbGpPWpGaD
Pentostatin—Alopecia—Epirubicin—urinary bladder cancer	3.61e-05	0.000585	CcSEcCtD
Pentostatin—Nausea—Gemcitabine—urinary bladder cancer	3.6e-05	0.000584	CcSEcCtD
Pentostatin—Vomiting—Cisplatin—urinary bladder cancer	3.6e-05	0.000583	CcSEcCtD
Pentostatin—ADA—Metabolism—GSTM1—urinary bladder cancer	3.59e-05	0.00156	CbGpPWpGaD
Pentostatin—ADA—Metabolism—NCOR1—urinary bladder cancer	3.59e-05	0.00156	CbGpPWpGaD
Pentostatin—Rash—Cisplatin—urinary bladder cancer	3.57e-05	0.000578	CcSEcCtD
Pentostatin—Dermatitis—Cisplatin—urinary bladder cancer	3.56e-05	0.000577	CcSEcCtD
Pentostatin—Diarrhoea—Etoposide—urinary bladder cancer	3.54e-05	0.000574	CcSEcCtD
Pentostatin—Nausea—Fluorouracil—urinary bladder cancer	3.54e-05	0.000574	CcSEcCtD
Pentostatin—Tinnitus—Doxorubicin—urinary bladder cancer	3.53e-05	0.000571	CcSEcCtD
Pentostatin—Anaemia—Methotrexate—urinary bladder cancer	3.51e-05	0.00057	CcSEcCtD
Pentostatin—Flatulence—Epirubicin—urinary bladder cancer	3.51e-05	0.000568	CcSEcCtD
Pentostatin—Tension—Epirubicin—urinary bladder cancer	3.49e-05	0.000566	CcSEcCtD
Pentostatin—Nervousness—Epirubicin—urinary bladder cancer	3.46e-05	0.00056	CcSEcCtD
Pentostatin—ADA—Metabolism—GPX1—urinary bladder cancer	3.44e-05	0.00149	CbGpPWpGaD
Pentostatin—Dizziness—Etoposide—urinary bladder cancer	3.43e-05	0.000555	CcSEcCtD
Pentostatin—Vertigo—Methotrexate—urinary bladder cancer	3.42e-05	0.000554	CcSEcCtD
Pentostatin—Leukopenia—Methotrexate—urinary bladder cancer	3.4e-05	0.000552	CcSEcCtD
Pentostatin—Chills—Doxorubicin—urinary bladder cancer	3.39e-05	0.00055	CcSEcCtD
Pentostatin—Arrhythmia—Doxorubicin—urinary bladder cancer	3.38e-05	0.000548	CcSEcCtD
Pentostatin—ADA—Metabolism—ERCC2—urinary bladder cancer	3.38e-05	0.00146	CbGpPWpGaD
Pentostatin—Nausea—Cisplatin—urinary bladder cancer	3.36e-05	0.000544	CcSEcCtD
Pentostatin—Alopecia—Doxorubicin—urinary bladder cancer	3.34e-05	0.000542	CcSEcCtD
Pentostatin—Cough—Methotrexate—urinary bladder cancer	3.32e-05	0.000538	CcSEcCtD
Pentostatin—Convulsion—Methotrexate—urinary bladder cancer	3.29e-05	0.000534	CcSEcCtD
Pentostatin—Vomiting—Etoposide—urinary bladder cancer	3.29e-05	0.000534	CcSEcCtD
Pentostatin—Anaemia—Epirubicin—urinary bladder cancer	3.29e-05	0.000533	CcSEcCtD
Pentostatin—Agitation—Epirubicin—urinary bladder cancer	3.27e-05	0.00053	CcSEcCtD
Pentostatin—Rash—Etoposide—urinary bladder cancer	3.27e-05	0.000529	CcSEcCtD
Pentostatin—Dermatitis—Etoposide—urinary bladder cancer	3.26e-05	0.000529	CcSEcCtD
Pentostatin—Headache—Etoposide—urinary bladder cancer	3.25e-05	0.000526	CcSEcCtD
Pentostatin—Flatulence—Doxorubicin—urinary bladder cancer	3.24e-05	0.000526	CcSEcCtD
Pentostatin—Arthralgia—Methotrexate—urinary bladder cancer	3.24e-05	0.000525	CcSEcCtD
Pentostatin—Myalgia—Methotrexate—urinary bladder cancer	3.24e-05	0.000525	CcSEcCtD
Pentostatin—Chest pain—Methotrexate—urinary bladder cancer	3.24e-05	0.000525	CcSEcCtD
Pentostatin—Tension—Doxorubicin—urinary bladder cancer	3.23e-05	0.000524	CcSEcCtD
Pentostatin—Nervousness—Doxorubicin—urinary bladder cancer	3.2e-05	0.000518	CcSEcCtD
Pentostatin—Vertigo—Epirubicin—urinary bladder cancer	3.2e-05	0.000518	CcSEcCtD
Pentostatin—Syncope—Epirubicin—urinary bladder cancer	3.19e-05	0.000517	CcSEcCtD
Pentostatin—Leukopenia—Epirubicin—urinary bladder cancer	3.19e-05	0.000516	CcSEcCtD
Pentostatin—ADA—Metabolism—MTHFR—urinary bladder cancer	3.18e-05	0.00138	CbGpPWpGaD
Pentostatin—Confusional state—Methotrexate—urinary bladder cancer	3.13e-05	0.000507	CcSEcCtD
Pentostatin—Loss of consciousness—Epirubicin—urinary bladder cancer	3.13e-05	0.000507	CcSEcCtD
Pentostatin—Cough—Epirubicin—urinary bladder cancer	3.11e-05	0.000503	CcSEcCtD
Pentostatin—Convulsion—Epirubicin—urinary bladder cancer	3.08e-05	0.0005	CcSEcCtD
Pentostatin—Infection—Methotrexate—urinary bladder cancer	3.08e-05	0.0005	CcSEcCtD
Pentostatin—Nausea—Etoposide—urinary bladder cancer	3.08e-05	0.000499	CcSEcCtD
Pentostatin—Hypertension—Epirubicin—urinary bladder cancer	3.07e-05	0.000498	CcSEcCtD
Pentostatin—Nervous system disorder—Methotrexate—urinary bladder cancer	3.04e-05	0.000493	CcSEcCtD
Pentostatin—Anaemia—Doxorubicin—urinary bladder cancer	3.04e-05	0.000493	CcSEcCtD
Pentostatin—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.04e-05	0.000492	CcSEcCtD
Pentostatin—Arthralgia—Epirubicin—urinary bladder cancer	3.03e-05	0.000491	CcSEcCtD
Pentostatin—Myalgia—Epirubicin—urinary bladder cancer	3.03e-05	0.000491	CcSEcCtD
Pentostatin—Chest pain—Epirubicin—urinary bladder cancer	3.03e-05	0.000491	CcSEcCtD
Pentostatin—Agitation—Doxorubicin—urinary bladder cancer	3.03e-05	0.00049	CcSEcCtD
Pentostatin—Anxiety—Epirubicin—urinary bladder cancer	3.02e-05	0.000489	CcSEcCtD
Pentostatin—Skin disorder—Methotrexate—urinary bladder cancer	3.01e-05	0.000488	CcSEcCtD
Pentostatin—Hyperhidrosis—Methotrexate—urinary bladder cancer	3e-05	0.000486	CcSEcCtD
Pentostatin—Vertigo—Doxorubicin—urinary bladder cancer	2.96e-05	0.000479	CcSEcCtD
Pentostatin—Anorexia—Methotrexate—urinary bladder cancer	2.96e-05	0.000479	CcSEcCtD
Pentostatin—Syncope—Doxorubicin—urinary bladder cancer	2.95e-05	0.000479	CcSEcCtD
Pentostatin—Leukopenia—Doxorubicin—urinary bladder cancer	2.95e-05	0.000478	CcSEcCtD
Pentostatin—Confusional state—Epirubicin—urinary bladder cancer	2.93e-05	0.000475	CcSEcCtD
Pentostatin—Hypotension—Methotrexate—urinary bladder cancer	2.9e-05	0.00047	CcSEcCtD
Pentostatin—Loss of consciousness—Doxorubicin—urinary bladder cancer	2.89e-05	0.000469	CcSEcCtD
Pentostatin—Infection—Epirubicin—urinary bladder cancer	2.89e-05	0.000468	CcSEcCtD
Pentostatin—Cough—Doxorubicin—urinary bladder cancer	2.87e-05	0.000466	CcSEcCtD
Pentostatin—Shock—Epirubicin—urinary bladder cancer	2.86e-05	0.000463	CcSEcCtD
Pentostatin—Convulsion—Doxorubicin—urinary bladder cancer	2.85e-05	0.000462	CcSEcCtD
Pentostatin—Nervous system disorder—Epirubicin—urinary bladder cancer	2.85e-05	0.000462	CcSEcCtD
Pentostatin—Thrombocytopenia—Epirubicin—urinary bladder cancer	2.84e-05	0.000461	CcSEcCtD
Pentostatin—Hypertension—Doxorubicin—urinary bladder cancer	2.84e-05	0.000461	CcSEcCtD
Pentostatin—Tachycardia—Epirubicin—urinary bladder cancer	2.83e-05	0.000459	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	2.83e-05	0.000458	CcSEcCtD
Pentostatin—Skin disorder—Epirubicin—urinary bladder cancer	2.82e-05	0.000457	CcSEcCtD
Pentostatin—Hyperhidrosis—Epirubicin—urinary bladder cancer	2.81e-05	0.000455	CcSEcCtD
Pentostatin—Insomnia—Methotrexate—urinary bladder cancer	2.81e-05	0.000455	CcSEcCtD
Pentostatin—Myalgia—Doxorubicin—urinary bladder cancer	2.8e-05	0.000454	CcSEcCtD
Pentostatin—Chest pain—Doxorubicin—urinary bladder cancer	2.8e-05	0.000454	CcSEcCtD
Pentostatin—Arthralgia—Doxorubicin—urinary bladder cancer	2.8e-05	0.000454	CcSEcCtD
Pentostatin—Anxiety—Doxorubicin—urinary bladder cancer	2.79e-05	0.000453	CcSEcCtD
Pentostatin—Paraesthesia—Methotrexate—urinary bladder cancer	2.79e-05	0.000452	CcSEcCtD
Pentostatin—Anorexia—Epirubicin—urinary bladder cancer	2.77e-05	0.000449	CcSEcCtD
Pentostatin—Dyspnoea—Methotrexate—urinary bladder cancer	2.77e-05	0.000448	CcSEcCtD
Pentostatin—Somnolence—Methotrexate—urinary bladder cancer	2.76e-05	0.000447	CcSEcCtD
Pentostatin—Dyspepsia—Methotrexate—urinary bladder cancer	2.73e-05	0.000443	CcSEcCtD
Pentostatin—Hypotension—Epirubicin—urinary bladder cancer	2.71e-05	0.00044	CcSEcCtD
Pentostatin—Confusional state—Doxorubicin—urinary bladder cancer	2.71e-05	0.000439	CcSEcCtD
Pentostatin—Decreased appetite—Methotrexate—urinary bladder cancer	2.7e-05	0.000437	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	2.68e-05	0.000434	CcSEcCtD
Pentostatin—Fatigue—Methotrexate—urinary bladder cancer	2.68e-05	0.000434	CcSEcCtD
Pentostatin—Infection—Doxorubicin—urinary bladder cancer	2.67e-05	0.000433	CcSEcCtD
Pentostatin—Pain—Methotrexate—urinary bladder cancer	2.65e-05	0.00043	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	2.65e-05	0.000429	CcSEcCtD
Pentostatin—Shock—Doxorubicin—urinary bladder cancer	2.64e-05	0.000428	CcSEcCtD
Pentostatin—Nervous system disorder—Doxorubicin—urinary bladder cancer	2.64e-05	0.000427	CcSEcCtD
Pentostatin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	2.63e-05	0.000426	CcSEcCtD
Pentostatin—Insomnia—Epirubicin—urinary bladder cancer	2.63e-05	0.000426	CcSEcCtD
Pentostatin—Tachycardia—Doxorubicin—urinary bladder cancer	2.62e-05	0.000425	CcSEcCtD
Pentostatin—Skin disorder—Doxorubicin—urinary bladder cancer	2.61e-05	0.000423	CcSEcCtD
Pentostatin—Paraesthesia—Epirubicin—urinary bladder cancer	2.61e-05	0.000423	CcSEcCtD
Pentostatin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	2.6e-05	0.000421	CcSEcCtD
Pentostatin—Dyspnoea—Epirubicin—urinary bladder cancer	2.59e-05	0.00042	CcSEcCtD
Pentostatin—Somnolence—Epirubicin—urinary bladder cancer	2.58e-05	0.000418	CcSEcCtD
Pentostatin—ADA—Metabolism—PPARG—urinary bladder cancer	2.57e-05	0.00112	CbGpPWpGaD
Pentostatin—Anorexia—Doxorubicin—urinary bladder cancer	2.56e-05	0.000415	CcSEcCtD
Pentostatin—Feeling abnormal—Methotrexate—urinary bladder cancer	2.56e-05	0.000414	CcSEcCtD
Pentostatin—Dyspepsia—Epirubicin—urinary bladder cancer	2.56e-05	0.000414	CcSEcCtD
Pentostatin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	2.54e-05	0.000411	CcSEcCtD
Pentostatin—Decreased appetite—Epirubicin—urinary bladder cancer	2.52e-05	0.000409	CcSEcCtD
Pentostatin—Hypotension—Doxorubicin—urinary bladder cancer	2.51e-05	0.000407	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.51e-05	0.000406	CcSEcCtD
Pentostatin—Fatigue—Epirubicin—urinary bladder cancer	2.5e-05	0.000406	CcSEcCtD
Pentostatin—Pain—Epirubicin—urinary bladder cancer	2.48e-05	0.000402	CcSEcCtD
Pentostatin—Constipation—Epirubicin—urinary bladder cancer	2.48e-05	0.000402	CcSEcCtD
Pentostatin—ADA—Metabolism—CREBBP—urinary bladder cancer	2.47e-05	0.00107	CbGpPWpGaD
Pentostatin—Urticaria—Methotrexate—urinary bladder cancer	2.47e-05	0.0004	CcSEcCtD
Pentostatin—Abdominal pain—Methotrexate—urinary bladder cancer	2.45e-05	0.000398	CcSEcCtD
Pentostatin—Body temperature increased—Methotrexate—urinary bladder cancer	2.45e-05	0.000398	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	2.45e-05	0.000397	CcSEcCtD
Pentostatin—Insomnia—Doxorubicin—urinary bladder cancer	2.43e-05	0.000394	CcSEcCtD
Pentostatin—Paraesthesia—Doxorubicin—urinary bladder cancer	2.41e-05	0.000391	CcSEcCtD
Pentostatin—Dyspnoea—Doxorubicin—urinary bladder cancer	2.4e-05	0.000388	CcSEcCtD
Pentostatin—Feeling abnormal—Epirubicin—urinary bladder cancer	2.39e-05	0.000388	CcSEcCtD
Pentostatin—Somnolence—Doxorubicin—urinary bladder cancer	2.39e-05	0.000387	CcSEcCtD
Pentostatin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.37e-05	0.000385	CcSEcCtD
Pentostatin—Dyspepsia—Doxorubicin—urinary bladder cancer	2.37e-05	0.000383	CcSEcCtD
Pentostatin—Decreased appetite—Doxorubicin—urinary bladder cancer	2.34e-05	0.000379	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.32e-05	0.000376	CcSEcCtD
Pentostatin—Fatigue—Doxorubicin—urinary bladder cancer	2.32e-05	0.000375	CcSEcCtD
Pentostatin—Urticaria—Epirubicin—urinary bladder cancer	2.31e-05	0.000374	CcSEcCtD
Pentostatin—Pain—Doxorubicin—urinary bladder cancer	2.3e-05	0.000372	CcSEcCtD
Pentostatin—Constipation—Doxorubicin—urinary bladder cancer	2.3e-05	0.000372	CcSEcCtD
Pentostatin—Body temperature increased—Epirubicin—urinary bladder cancer	2.3e-05	0.000372	CcSEcCtD
Pentostatin—Abdominal pain—Epirubicin—urinary bladder cancer	2.3e-05	0.000372	CcSEcCtD
Pentostatin—Hypersensitivity—Methotrexate—urinary bladder cancer	2.29e-05	0.000371	CcSEcCtD
Pentostatin—Asthenia—Methotrexate—urinary bladder cancer	2.23e-05	0.000361	CcSEcCtD
Pentostatin—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.21e-05	0.000359	CcSEcCtD
Pentostatin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.2e-05	0.000356	CcSEcCtD
Pentostatin—Pruritus—Methotrexate—urinary bladder cancer	2.2e-05	0.000356	CcSEcCtD
Pentostatin—Hypersensitivity—Epirubicin—urinary bladder cancer	2.14e-05	0.000347	CcSEcCtD
Pentostatin—Urticaria—Doxorubicin—urinary bladder cancer	2.13e-05	0.000346	CcSEcCtD
Pentostatin—Body temperature increased—Doxorubicin—urinary bladder cancer	2.12e-05	0.000344	CcSEcCtD
Pentostatin—Abdominal pain—Doxorubicin—urinary bladder cancer	2.12e-05	0.000344	CcSEcCtD
Pentostatin—Diarrhoea—Methotrexate—urinary bladder cancer	2.12e-05	0.000344	CcSEcCtD
Pentostatin—Asthenia—Epirubicin—urinary bladder cancer	2.08e-05	0.000338	CcSEcCtD
Pentostatin—Pruritus—Epirubicin—urinary bladder cancer	2.05e-05	0.000333	CcSEcCtD
Pentostatin—Dizziness—Methotrexate—urinary bladder cancer	2.05e-05	0.000333	CcSEcCtD
Pentostatin—ADA—Metabolism—PTGS2—urinary bladder cancer	2.03e-05	0.000878	CbGpPWpGaD
Pentostatin—Diarrhoea—Epirubicin—urinary bladder cancer	1.99e-05	0.000322	CcSEcCtD
Pentostatin—Hypersensitivity—Doxorubicin—urinary bladder cancer	1.98e-05	0.000321	CcSEcCtD
Pentostatin—Vomiting—Methotrexate—urinary bladder cancer	1.97e-05	0.00032	CcSEcCtD
Pentostatin—Rash—Methotrexate—urinary bladder cancer	1.96e-05	0.000317	CcSEcCtD
Pentostatin—Dermatitis—Methotrexate—urinary bladder cancer	1.95e-05	0.000317	CcSEcCtD
Pentostatin—Headache—Methotrexate—urinary bladder cancer	1.94e-05	0.000315	CcSEcCtD
Pentostatin—Asthenia—Doxorubicin—urinary bladder cancer	1.93e-05	0.000312	CcSEcCtD
Pentostatin—Dizziness—Epirubicin—urinary bladder cancer	1.92e-05	0.000311	CcSEcCtD
Pentostatin—Pruritus—Doxorubicin—urinary bladder cancer	1.9e-05	0.000308	CcSEcCtD
Pentostatin—Vomiting—Epirubicin—urinary bladder cancer	1.85e-05	0.000299	CcSEcCtD
Pentostatin—Nausea—Methotrexate—urinary bladder cancer	1.84e-05	0.000299	CcSEcCtD
Pentostatin—Diarrhoea—Doxorubicin—urinary bladder cancer	1.84e-05	0.000298	CcSEcCtD
Pentostatin—Rash—Epirubicin—urinary bladder cancer	1.83e-05	0.000297	CcSEcCtD
Pentostatin—Dermatitis—Epirubicin—urinary bladder cancer	1.83e-05	0.000296	CcSEcCtD
Pentostatin—Headache—Epirubicin—urinary bladder cancer	1.82e-05	0.000295	CcSEcCtD
Pentostatin—Dizziness—Doxorubicin—urinary bladder cancer	1.78e-05	0.000288	CcSEcCtD
Pentostatin—ADA—Metabolism—PTEN—urinary bladder cancer	1.77e-05	0.000766	CbGpPWpGaD
Pentostatin—Nausea—Epirubicin—urinary bladder cancer	1.73e-05	0.00028	CcSEcCtD
Pentostatin—Vomiting—Doxorubicin—urinary bladder cancer	1.71e-05	0.000277	CcSEcCtD
Pentostatin—Rash—Doxorubicin—urinary bladder cancer	1.69e-05	0.000275	CcSEcCtD
Pentostatin—Dermatitis—Doxorubicin—urinary bladder cancer	1.69e-05	0.000274	CcSEcCtD
Pentostatin—ADA—Metabolism—EP300—urinary bladder cancer	1.68e-05	0.00073	CbGpPWpGaD
Pentostatin—Headache—Doxorubicin—urinary bladder cancer	1.68e-05	0.000273	CcSEcCtD
Pentostatin—Nausea—Doxorubicin—urinary bladder cancer	1.6e-05	0.000259	CcSEcCtD
